Literature DB >> 15138004

Antiplasmodial studies of Eurycoma longifolia Jack using the lactate dehydrogenase assay of Plasmodium falciparum.

Kit-Lam Chan1, Chee-Yan Choo, Noor Rain Abdullah, Zakiah Ismail.   

Abstract

The roots of Eurycoma longifolia Jack have been used as traditional medicine to treat malaria. A systematic bioactivity-guided fractionation of this plant was conducted involving the determination of the effect of its various extracts and their chemical constituents on the lactate dehydrogenase activity of in vitro chloroquine-resistant Gombak A isolate and chloroquine-sensitive D10 strain of Plasmodium falciparum parasites. Their antiplasmodial activity was also compared with their known in vitro cytotoxicity against KB cells. Four quassinoids, eurycomanone (1), 13,21-dihydroeurycomanone (3), 13 alpha(21)-epoxyeurycomanone (4), eurycomalactone (6) and an alkaloid, 9-methoxycanthin-6-one (7), displayed higher antiplasmodial activity against Gombak A isolate but were less active against the D10 strain when compared with chloroquine. Amongst the compounds tested, 1 and 3 showed higher selectivity indices obtained for the cytotoxicity to antiplasmodial activity ratio than 14,15 beta-dihydroxyklaineanone (2), eurycomanol (5), 6 and 7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138004     DOI: 10.1016/j.jep.2004.02.025

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  23 in total

1.  Antiplasmodial activity of botanical extracts against Plasmodium falciparum.

Authors:  Asokan Bagavan; Abdul Abdul Rahuman; Chinnaperumal Kamaraj; Naveen Kumar Kaushik; Dinesh Mohanakrishnan; Dinkar Sahal
Journal:  Parasitol Res       Date:  2010-11-16       Impact factor: 2.289

2.  In vitro anti-plasmodial activity of some traditionally used medicinal plants against Plasmodium falciparum.

Authors:  V Venkatesalu; N Gopalan; C R Pillai; Vineeta Singh; M Chandrasekaran; A Senthilkumar; N Chandramouli
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

3.  Two new antimalarial quassinoid derivatives from the stems of Brucea javanica.

Authors:  Parinuch Chumkaew; Jaraslak Pechwang; Theera Srisawat
Journal:  J Nat Med       Date:  2017-04-28       Impact factor: 2.343

4.  The effect of eurycoma longifolia Jack on spermatogenesis in estrogen-treated rats.

Authors:  Norhazlina Abdul Wahab; Norfilza M Mokhtar; Wan Nurul Heriza A Halim; Srijit Das
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  4,5,7,8,17-Penta-hydr-oxy-14,18-dimethyl-6-methyl-ene-3,10-dioxapenta-cyclo-[9.8.0.0.0.0]nona-dec-14-ene-9,16-dione methanol solvate dihydrate.

Authors:  Chin Hoe Teh; Siew Chin Teoh; Chin Sing Yeap; Kit Lam Chan; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-28

6.  Activity of Eurycoma longifolia root extract against Plasmodium falciparum in vitro.

Authors:  Walther H Wernsdorfer; Sabariah Ismail; Kit Lam Chan; Kanungnit Congpuong; Gunther Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

7.  Role of medicinal plants and natural products on osteoporotic fracture healing.

Authors:  Mohd Azri Abd Jalil; Ahmad Nazrun Shuid; Norliza Muhammad
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-02       Impact factor: 2.629

8.  In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack.

Authors:  Nowroji Kavitha; Rahmah Noordin; Kit-Lam Chan; Sreenivasan Sasidharan
Journal:  BMC Complement Altern Med       Date:  2012-07-10       Impact factor: 3.659

9.  Assessment of antiproliferative and antiplasmodial activities of five selected Apocynaceae species.

Authors:  Siu Kuin Wong; Yau Yan Lim; Noor Rain Abdullah; Fariza Juliana Nordin
Journal:  BMC Complement Altern Med       Date:  2011-01-14       Impact factor: 3.659

10.  In Vitro Anti-plasmodial activity of Trigonella foenum-graecum L.

Authors:  M Palaniswamy; B V Pradeep; R Sathya; J Angayarkanni
Journal:  Evid Based Complement Alternat Med       Date:  2008-05-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.